Search

Haleon PLC

Atidarymo kaina

SektoriusSveikatos priežiūra

377.5 0.24

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

370.5

Max

379.6

Pagrindiniai rodikliai

By Trading Economics

Pajamos

-254M

231M

Pardavimai

-21M

2.8B

P/E

Sektoriaus vid.

23.781

57.333

Pelnas, tenkantis vienai akcijai

0.042

Dividendų pajamingumas

1.73

Pelno marža

8.373

Darbuotojai

24,561

EBITDA

-317M

399M

Rekomendacijos

By TipRanks

Rekomendacijos

Pirkti

12 mėnesių prognozė

+6.54% upside

Dividendai

By Dow Jones

Dividendų pajamingumas

Sektoriaus vid.

1.73%

2.63%

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

297M

34B

Ankstesnė atidarymo kaina

377.26

Ankstesnė uždarymo kaina

377.5

Haleon PLC Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2025-04-15 09:37; UTC

Įsigijimai, susijungimai, perėmimai

Haleon Acquires Chinese JV in $264 Million Deal

2025-03-19 07:34; UTC

Įsigijimai, susijungimai, perėmimai

Pfizer Sells Remaining 7.3% Haleon Shareholding for $3.25 Billion

2025-03-18 17:26; UTC

Įsigijimai, susijungimai, perėmimai

Pfizer to Dispose of Remaining Shareholding in Haleon

2025-02-27 07:43; UTC

Uždarbis

Haleon Expects Further Growth After Profit Rises

2025-04-15 09:03; UTC

Įsigijimai, susijungimai, perėmimai

Haleon: Deal Expected to Close Within Next Three Mos

2025-04-15 09:03; UTC

Įsigijimai, susijungimai, perėmimai

Haleon Has Bought Last 12% Interest for GBP200M

2025-04-15 09:02; UTC

Įsigijimai, susijungimai, perėmimai

Haleon Bought 33% interest in December 2024

2025-04-15 09:02; UTC

Įsigijimai, susijungimai, perėmimai

Haleon Buys 33% Interest in Tianjin TSKF Pharmaceutical from Tianjin Pharmaceutical Da Ren Tang

2025-04-15 09:01; UTC

Įsigijimai, susijungimai, perėmimai

Haleon Buys 33% Interest in Tianjin TSKF Pharmaceutical

2025-03-18 16:58; UTC

Įsigijimai, susijungimai, perėmimai

Haleon Intends to Cancel Purchased Ordinary Shares

2025-03-18 16:57; UTC

Įsigijimai, susijungimai, perėmimai

Citigroup: Off-Market Transaction Will Close at Same Time as or Following Settlement of Offering

2025-03-18 16:56; UTC

Įsigijimai, susijungimai, perėmimai

Citigroup: Off-Market Purchase Worth Approx GBP170M in Ordinary Shares

2025-03-18 16:56; UTC

Įsigijimai, susijungimai, perėmimai

Citigroup: Haleon Agreed to Carry out Off-Market Purchase From Pfizer

2025-03-18 16:52; UTC

Įsigijimai, susijungimai, perėmimai

Haleon Takes Note of Announcement

2025-03-18 16:50; UTC

Įsigijimai, susijungimai, perėmimai

Citigroup: Haleon Won't Receive Any Net Proceeds From Offering

2025-03-18 16:50; UTC

Įsigijimai, susijungimai, perėmimai

Citigroup: This Is Subject to Customary Closing Conditions

2025-03-18 16:50; UTC

Įsigijimai, susijungimai, perėmimai

Citigroup: Pfizer Will Receive All of Net Proceeds From Offering

2025-03-18 16:49; UTC

Įsigijimai, susijungimai, perėmimai

Citigroup: Bookbuilding Period May Close at Any Time on Short Notice

2025-03-18 16:49; UTC

Įsigijimai, susijungimai, perėmimai

Citigroup: Bookbuilding Period Will Commence Immediately

2025-03-18 16:49; UTC

Įsigijimai, susijungimai, perėmimai

Citigroup: Price Per Sale Share to Be Determined Through Accelerated Bookbuilding Process

2025-03-18 16:48; UTC

Įsigijimai, susijungimai, perėmimai

Citigroup: Pfizer Intends to Sell Ordinary Shares to Institutional Investors

2025-03-18 16:47; UTC

Įsigijimai, susijungimai, perėmimai

Citigroup:: Amount Is Pfizer's Entire Residual Shareholding in Haleon

2025-03-18 16:47; UTC

Įsigijimai, susijungimai, perėmimai

Citigroup: This Represents Approx 7.3% Stake in Haleon

2025-03-18 16:46; UTC

Įsigijimai, susijungimai, perėmimai

Citigroup: Pfizer Intends to Sell Approx 662M Ordinary Shares in Haleon

2025-02-27 10:14; UTC

Rinkos pokalbiai
Uždarbis

Haleon's EPS Beat Is Reassuring -- Market Talk

2025-02-27 07:58; UTC

Rinkos pokalbiai
Uždarbis

Haleon's Results Are Consistent -- Market Talk

2025-02-27 07:04; UTC

Uždarbis

Haleon Sees 2025 Organic Operating Profit Growth Ahead of Organic Rev Growth

2025-02-27 07:04; UTC

Uždarbis

Haleon Backs Mid-Term Targets

2025-02-27 07:03; UTC

Uždarbis

Haleon Sees 2025 Organic Revenue Growth of 4%-6%

2025-02-27 07:03; UTC

Uždarbis

Haleon 2024 EPS 15.7p

Haleon PLC Prognozė

Kainos tikslas

By TipRanks

6.54% į viršų

12 mėnesių prognozė

Vidutinis 405.5 GBX  6.54%

Aukščiausias 460 GBX

Žemiausias 315 GBX

Remiantis 10 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Haleon PLC kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Pirkti

10 ratings

5

Pirkti

4

Laikyti

1

Parduoti

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Haleon PLC

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands. It also offers various over-the-counter products comprising nasal drops, and cold, flu, and allergy relief products under Otrivine, Theraflu, and Flonase brands for respiratory issues; anti-inflammatory and pain relief products under Voltaren, Panadol, and Advil brands; and antacids and antihistamine products under TUMS, ENO, and Fenistil brands for digestive health and other issues. The company was formerly known as DRVW 2022 plc and changed its name to Haleon plc in February 2022. Haleon plc was founded in 1715 and is headquartered in Weybridge, the United Kingdom.